(19)
(11) EP 3 310 363 A1

(12)

(43) Date of publication:
25.04.2018 Bulletin 2018/17

(21) Application number: 16812480.8

(22) Date of filing: 17.06.2016
(51) International Patent Classification (IPC): 
A61K 33/22(2006.01)
A61P 31/00(2006.01)
A61K 31/78(2006.01)
(86) International application number:
PCT/US2016/037947
(87) International publication number:
WO 2016/205574 (22.12.2016 Gazette 2016/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 18.06.2015 US 201562181202 P

(71) Applicants:
  • Common Pharma, Inc
    San Carlos, CA 94070 (US)
  • Memarzadeh, Bahram
    San Carlos, CA 94070 (US)

(72) Inventor:
  • MEMARZADEH, Bahram
    San Carlos, CA 94070 (US)

(74) Representative: Evans, Jacqueline Gail Victoria 
Marches Intellectual Property Limited Wyastone Business Park Wyastone Leys Ganarew
Monmouth NP25 3SR
Monmouth NP25 3SR (GB)

   


(54) ANTIMICROBIAL FORMULATIONS